These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38214545)

  • 1. Treatment patterns and drug survival for generalized pustular psoriasis: A patient journey study using a Japanese claims database.
    Tada Y; Guan J; Iwasaki R; Morita A
    J Dermatol; 2024 Mar; 51(3):391-402. PubMed ID: 38214545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with generalized pustular psoriasis progression among patients with psoriasis vulgaris in Japan: Results from a claims database study.
    Hayama K; Iwasaki R; Tian Y; Fujita H
    J Dermatol; 2023 Dec; 50(12):1531-1538. PubMed ID: 37721393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan.
    Miyachi H; Konishi T; Kumazawa R; Matsui H; Shimizu S; Fushimi K; Matsue H; Yasunaga H
    J Am Acad Dermatol; 2022 Jun; 86(6):1266-1274. PubMed ID: 34116101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological survey of patients with pustular psoriasis in the Japanese Society for Psoriasis Research from 2017 to 2020.
    Kamiya K; Ohtsuki M
    J Dermatol; 2023 Jan; 50(1):3-11. PubMed ID: 36152301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database.
    Morita A; Kotowsky N; Gao R; Shimizu R; Okubo Y
    J Dermatol; 2021 Oct; 48(10):1463-1473. PubMed ID: 34212422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search.
    Puig L; Fujita H; Thaçi D; Zheng M; Hernandez Daly AC; Leonardi C; Lebwohl MG; Barker J
    Dermatol Ther (Heidelb); 2024 Sep; 14(9):2331-2378. PubMed ID: 39088126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
    Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
    Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug survival of biologic agents for psoriatic patients in a real-world setting in Japan.
    Kishimoto M; Komine M; Kamiya K; Sugai J; Mieno M; Ohtsuki M
    J Dermatol; 2020 Jan; 47(1):33-40. PubMed ID: 31696543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years.
    Umezawa Y; Mabuch T; Ozawa A
    Pediatr Dermatol; 2012; 29(2):206-8. PubMed ID: 22409471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study.
    Ohata C; Tsuruta N; Yonekura K; Higashi Y; Saito K; Katayama E; Imafuku S;
    J Dermatol; 2022 Jan; 49(1):142-150. PubMed ID: 34723399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database.
    Miyazaki C; Masuda J; Tsai PI; Saeki H
    Dermatol Ther (Heidelb); 2024 Oct; ():. PubMed ID: 39407051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns, healthcare resource utilization, and costs in patients with moderate-to-severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study.
    Tada Y; Kim H; Spanopoulos D; Habiro K; Tsuritani K; Yamada Y; Mandal A; Zhong Y; Hikichi Y
    J Dermatol; 2022 Nov; 49(11):1106-1117. PubMed ID: 35946343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.
    Ho PH; Tsai TF
    J Dermatol; 2018 Nov; 45(11):1353-1356. PubMed ID: 30230584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databases.
    Feldman SR; Bohn RL; Gao R; Gray S; Walton SE; Déruaz-Luyet A; Wu JJ
    JAAD Int; 2024 Jun; 15():78-83. PubMed ID: 38440298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the Japanese Medical Data Center database.
    Okubo Y; Kotowsky N; Gao R; Saito K; Morita A
    J Dermatol; 2021 Nov; 48(11):1675-1687. PubMed ID: 34390028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug survival in the treatment of generalized pustular psoriasis: A retrospective multicenter study.
    Kromer C; Loewe E; Schaarschmidt ML; Pinter A; Gerdes S; Herr R; Poortinga S; Moessner R; Wilsmann-Theis D
    Dermatol Ther; 2021 Mar; 34(2):e14814. PubMed ID: 33497511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized pustular psoriasis: current management status and unmet medical needs in Japan.
    Komine M; Morita A
    Expert Rev Clin Immunol; 2021 Sep; 17(9):1015-1027. PubMed ID: 34402355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database.
    Sruamsiri R; Iwasaki K; Tang W; Mahlich J
    BMC Dermatol; 2018 Jul; 18(1):5. PubMed ID: 29996929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study.
    Wang C; Torisu-Itakura H; Hanada T; Matsuo T; Cai Z; Osaga S; Aranishi T
    J Dermatolog Treat; 2023 Dec; 34(1):2229465. PubMed ID: 37403477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.